RT Journal Article
SR Electronic
T1 Encoding generation time changes within reproduction numbers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.19.22281255
DO 10.1101/2022.10.19.22281255
A1 Parag, Kris V
A1 Cowling, Benjamin J
A1 Lambert, Ben C
YR 2022
UL http://medrxiv.org/content/early/2022/11/28/2022.10.19.22281255.abstract
AB We derive and introduce the angular reproduction number, Ω, which measures time-varying changes in epidemic transmissibility resulting from variations in both the effective reproduction number, R, and the generation time distribution, w. Predominant approaches for tracking the dynamics of pathogen spread either infer R or the epidemic growth rate r. However, R is easily biased by mismatches between the assumed and true w, while r is difficult to interpret in terms of the individual-level branching process underpinning transmission. Moreover, R and r may disagree on the relative transmissibility of two epidemics or variants (i.e., rA > rB does not imply RA > RB for variants A and B). We find that Ω responds meaningfully to mismatches in w while maintaining most of the interpretability of R. Additionally, we prove that Ω > 1 if and only if R > 1 and that Ω agrees with r on the relative transmissibility of pathogens. Estimating Ω is no harder than inferring R, uses existing software, and requires no generation time measurement. These advantages come at the expense of selecting one free parameter. We propose Ω as a useful statistic for tracking and comparing the spread of infectious diseases that may better reflect the impact of interventions when those interventions concurrently change both R and w or alter the relative risk of co-circulating pathogens.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKVP acknowledges funding from the MRC Centre for Global Infectious Disease Analysis (reference MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code (in MATLAB and R) used to perform all analyses and for testing the statistic on user datasets are freely available at https://github.com/kpzoo/Omega https://github.com/kpzoo/Omega